Vividion Therapeutics competitorsClear all

Vividion Therapeutics's top competitors include CTD Holdings, Enanta Pharmaceuticals, CEL-SCI and U.S. Stem Cell.
Vividion Therapeutics
Vividion Therapeutics
Vividion is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome-wide drug and target discovery.
CTD Holdings
CTD Holdings
CTD Holdings, Inc., is a biotechnology company that develops cyclodextrin-based products for the treatment of diseases.
Enanta Pharmaceuticals
Enanta Pharmaceuticals
Enanta Pharmaceuticals is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs.
CEL-SCI
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
U.S. Stem Cell
U.S. Stem Cell
U.S. Stem Cell is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage.
Founding Date
Founding Date
2013
Founding Date
1990
Founding Date
1998
Founding Date
1983
Founding Date
N/A
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Princeton, US HQ
Locations
Alachua, US HQ
Locations
Watertown, US HQ
Locations
Vienna, US HQ
Locations
Sunrise, US HQ
Employees
Employees
N/A
Employees
525% increase
Employees
11327% increase
Employees
N/A
Employees
10
Valuation ($)
Valuation ($)
N/A
Valuation ($)
35.5 m
Valuation ($)
1.8 b
Valuation ($)
192.8 m
Valuation ($)
9.5 m
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
344
Twitter followers
1.9 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
5
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
6
Average likes per tweet (last 30 days)
0.4
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
40%
Alexa Website Rank
Alexa Website Rank
746069
Alexa Website Rank
245238
Alexa Website Rank
726427
Alexa Website Rank
834230
Alexa Website Rank
1117416

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$206.6m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
$6.7m (FY, 2018)
Cost of goods
Cost of goods
N/A
Cost of goods
$105k (FY, 2018)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$2.1m (FY, 2018)
Net income
Net income
N/A
Net income
($4.3m) (FY, 2018)
Net income
$72m (FY, 2018)
Net income
($31.8m) (FY, 2018)
Net income
($2.2m) (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 236.5m
Total funding raised
$ 1.7m
Total funding raised
$ 9.2m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

CTD Holdings
HQ
Alachua, US
Employees
5↑ 25% increase

CTD Holdings, Inc., is a biotechnology company that develops cyclodextrin-based products for the treatment of diseases.

View company
Enanta Pharmaceuticals
HQ
Watertown, US
Employees
113↑ 27% increase

Enanta Pharmaceuticals is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs.

View company
CEL-SCI
HQ
Vienna, US

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

View company
U.S. Stem Cell
HQ
Sunrise, US
Employees
10

U.S. Stem Cell is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage.

View company